Navigation Links
Glivec Enhances Survival Rates In Leukemia

Glivec, a drug used to treat chronic myeloid leukemia has shown to improve the survival rates in 90 percent of patients with the cancer.// The National Institute for health and Clinical Excellence (NICE), which regulates drug approvals in the UK had only wanted to approve Glivec for advanced cases, but the drug has not proved itself in clinical trials.

CML is a common form of blood cancer, which arises due to a defect in the production of white blood cells. Glivec targets only the affected molecules and leaves the healthy ones unaffected. But it is an expensive drug and costs at least ￡14,000 per patient per year.

Results from the IRIS study showed that 93 percent of patients taking the drug in early stages did not progress to advanced stage. Also 83 percent had good survival rate of five years. Before the introduction of Glivec, CML had poor prognosis with survival rates of only four to six years.

Sandy Craine, from CML Support, who took part in the trial said, "I never would have believed I would be standing here today. Glivec helped save my life and I am grateful that I can pass on this message of hope to others diagnosed with this once devastating disease."

Professor Charles Craddock, director of Stem Cell Transplant Unit, Queen Elizabeth Hospital, Birmingham, added, "The significant success of Glivec in treating CML is an exciting model for the development of new treatments for other cancers."
'"/>




Page: 1

Related medicine news :

1. Glivec - New Hope For CMC Patients
2. Glivec the hot cancer drug from Novartis
3. Animal Fat Enhances Risk Of Stomach
4. Tiagabine Enhances Sleep Maintenance In Insomnia Patients
5. Simulated Heart Tissue Enhances Understanding of Arrhythmias And Defibrillator Failure
6. Study Claims That Chemo Before And After Surgery Enhances Survival Rates
7. Common Virus Enhances Cancer-Fighting Ability of Standard Chemotherapy Drugs
8. Haryana Enhances Nutritional Support for Women, Children
9. Loop Incision Treatment Enhances Premature Delivery Risk
10. Long-Term Survival can be Predicted by a Simple Lung Test
11. Hepatitis G May Boost HIV Survival
Post Your Comments:
(Date:10/10/2008)...Coach Holly Warlick Teams Up with Legal and Medica...Ever Cancer and Careers Seminar in,Knoxville, KNO...ion of National,Breast Cancer Awareness Month, Can...e joined forces with YWCA Knoxville, The Wellness ...e Holly Warlick, University of Tennessee,women,s b...
(Date:10/10/2008)... The Healthcare Technology Ev... , Exton, PA (PRWEB) Sept...ey Chapters of the national Healthcare Information...forces to bring regional health information techno... conference entitled The Healthcare Technology Evo...
(Date:10/10/2008)...ston, MABoston Medical Center (BMC) has received a...l Institute on Aging (NIA) to fund the Boston Clau...BMC,s Pepper Center is one of only 11 Pepper Cente... Americans Independence Center Program was establi...enator from Florida. During his five decades of pu...
(Date:10/10/2008)...olecular CT adds metabolic information from PET to...gnostic imaging for maximized workflow ...ICH, Germany, Oct. 10 /PRNewswire/ -- Siemens Heal...duces molecular CT, a new concept in,integrated im...d is a,practical solution for today,s shrinking he...
Breaking Medicine News(10 mins):Health News:Local Experts Help Women Living and Working with Cancer Even the Score 2Health News:Local Experts Help Women Living and Working with Cancer Even the Score 3Health News:Local Experts Help Women Living and Working with Cancer Even the Score 4Health News:HIMSS New Jersey and Delaware Valley Chapters Sponsor Regional Conference 2Health News:Boston Medical Center receives $5.8m grant 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 2Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 3Health News:Siemens Shapes the Future of Integrated Diagnostic Imaging 4
...ists at the University of California in Los Angele...f the information to patients for them to take the...n that there is actually a lack of communication b...d the lead author Derjung M. Tarn. The study is pu...
...fe support at a hospital after a routine visit to ... receiving intravenous sedation.// Procedural sed...nxiety during routine medical and dental procedure...e girl, Diamond Brownridge told the WLS – TV that ...
...ne cancer is more lethal for black women. The stud... women// with uterine cancer survived for 10.2 mon...n the same treatment. Dr. G. Larry Maxwell and his...al Center in Washington, D.C said black women were...
...IDS is a major hindrance in controlling the fast-s.../. "Stigma and discrimination are indeed problem a...dik, special envoy of the UN secretary general for...ic. "There is acceptance of the problem at the hi...
Other Medicine News:Health News:Doctors to give complete information on prescriptions to patients 2Health News:Doctors to give complete information on prescriptions to patients 3Health News:Risks involved in Procedural Sedation 2Health News:Remove Stigma to Defeat HIV/AIDS in India, says UN Envoy 2
(Date:10/9/2008)...Scripps Translational Science Institute, Navigenic... health study, SAN DIEGO, Oct. 9 /- ...ch leaders have joined forces in a first-of-its-ki...of personal genetic testing,on people who choose t...ial,risk for developing certain diseases., Sponso...
(Date:10/8/2008)...ALEXANDRIA, Va., Oct. 8 /PRNewswire-USNewswire/ --...00 people die from HIV/AIDS in,sub-Saharan Africa....sub-Saharan Africa have already died of AIDS. The ...orking to ensure the dying and their families,find...f life. FHSSA,s,innovative partnering initiative l...
(Date:10/8/2008)...- Findings May Someday Inform Treatments for Spina.... 8 /PRNewswire-USNewswire/ -- A protein that enab...ys a key role in controlling,the developing nervou...cise,connections to form among nerve cells may pro...who suffer injuries to their nervous system,inclu...
(Date:10/8/2008)...iew Zanolimumab Program to be Discontinued and Hea...e Results of its Portfolio Review; Zanolimumab Pr...ce the Number of Emp...ll/ -- Genmab A/S (OMX: GEN),announced today that ...Max-CD4(R)). In addition, as a result of a portfol...
Breaking Medicine Technology:Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 2Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 3Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 4Landmark Research Study is Launched to Assess Impact of Personal Genetic Testing 5In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Protein Shown to Play a Key Role in Normal Development of Nervous System 2Protein Shown to Play a Key Role in Normal Development of Nervous System 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 2Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 3Genmab A/S - Company Announcement: Genmab Reports Results of Portfolio 4Stereotaxis Announces Fourth Quarter and Full Year 2007 Earnings Release Date and Conference Call 12656 1About one quarter of women with HIV want to become pregnant 12652 1About one quarter of women with HIV want to become pregnant 12652 2About one quarter of women with HIV want to become pregnant 12652 3About one quarter of women with HIV want to become pregnant 12652 4Danaher to Present at Citigroup Global Industrial Manufacturing Conference 12649 1Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 1Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 2Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 3Three Year Analysis of Treatment Efficacy Cosmesis and Toxicity Support use of the Hologic Mammosite Radiation Therapy System 1428 4
... The outcome of many illnesses for which patients ... improved dramatically over the past decades, desp...isticated mechanical and pharmacological support o...ients requiring intensive care for more than five ...al morbidity. Recently, however, evidence from a ...
...can be an essential element of patient assessment,...setting is often desirable. In keeping with the re... into easily used point-of-care devices, recent pr...essment of hemoglobin values., ,HemoCue, Inc.,...obin Test Systems provide quick, simple and reliab...
Other Medicine Technology:Tight Glycemic Control in the ICU 2Tight Glycemic Control in the ICU 3Hemoglobin Testing at the Point of Care 2Hemoglobin Testing at the Point of Care 3
Bipolar semi-floating pacing lead for temporary stimulation of the heart especially in emergency cases of bradycardial arrhythmias or for recording intracardiac ECGs.
VascoStim 2F are bipolar temporary pacing leads to be used in conjunction with thermodilution catheters with implemented paceport-channel.
Bipolar Ventricular Lead
Steroid-eluting, screw-in pacing lead
Medicine Products: